Synthesis and evaluation of a novel series of pseudo-cinnamic derivatives as antituberculosis agents. 2009

Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
Université de Toulouse, UPS, LSPCMIB (Laboratoire de Synthèse et Physico-Chimie de Molécules d'Intérêt Biologique), 118, Route de Narbonne, F-31062 Toulouse Cedex 9, France.

In an effort to develop potent new antituberculous drugs effective against Mycobacterium tuberculosis, we have prepared series of cinnamic derivatives (thioesters and amides) with 4-hydroxy and 4-alkoxy groups and investigated the in vitro activities of these compounds. Among them some displayed a good in vitro antibacterial activity, such as (E)-N-(2-acetamidoethyl)-3-{4-[(E)-3,7-dimethylocta-2,6-dienyloxy]phenyl}acrylamide 4b that showed a minimum inhibitory concentration of 0.1microg/mL (0.26microM) against M. tuberculosis H37Rv.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D002934 Cinnamates Derivatives of cinnamic acid (the structural formula: phenyl-HC Cinnamate
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular

Related Publications

Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
April 2012, European journal of medicinal chemistry,
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
October 2004, Journal of medicinal chemistry,
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
April 2014, Molecules (Basel, Switzerland),
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
August 2011, Bioorganic & medicinal chemistry,
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
February 2012, Expert opinion on therapeutic patents,
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
July 2010, Bioorganic & medicinal chemistry,
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
November 2011, European journal of medicinal chemistry,
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
December 2005, Journal of medicinal chemistry,
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
March 2008, Biochemical pharmacology,
Georges Koumba Yoya, and Florence Bedos-Belval, and Patricia Constant, and Hubert Duran, and Mamadou Daffé, and Michel Baltas
July 2014, Molecules (Basel, Switzerland),
Copied contents to your clipboard!